StockData

Regenerative Medical Technology Group Inc. (RMTG) stock

RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.04−0.00 (-5.76%)

Close on Oct 19, 2026Market cap $497.25KP/E –Yield –

Regenerative Medical Technology operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Regenerative Medical Technology's operating income for the twelve months ending Jun 30, 2026 was $43.73K, down 84.7% year over year. For fiscal 2025 it was -$867.16K, down 1168.2% from the year before.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$867.16K-1168.2%
FY2024Dec 31, 2024$81.18K–
FY2023Dec 31, 2023-$715.23K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$565.98K–
Q1 FY2026Mar 31, 2026$229.78K+70.3%
Q4 FY2025Dec 31, 2025-$306.27K-180.5%
Q3 FY2025Sep 30, 2025-$445.76K-2368.7%
Q2 FY2025Jun 30, 2025-$250.09K–
Q1 FY2025Mar 31, 2025$134.96K–
Q4 FY2024Dec 31, 2024$380.62K–
Q3 FY2024Sep 30, 2024$19.65K–
Q2 FY2024Jun 30, 2024-$213.98K–
Q1 FY2024Mar 31, 2024-$105.11K–

More Regenerative Medical Technology figures

See a number that looks wrong?